Articles by Justin Neway - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Justin Neway

Improving Technology Transfer

This article focuses on the growing need for effective data management in the life sciences industry—especially among smaller pharmaceutical manufacturers.
Nov 1, 2012

This article focuses on the growing need for effective data management in the life sciences industry—especially among smaller pharmaceutical manufacturers.

Biosimilars Increase the Need for IT to Reduce Variability

Aug 17, 2011

Using information technology tools to enhance process understanding helps reduce variability that can affect speed to market.

Intelligence Platforms Can Strengthen Relationships with Contractors

Jul 21, 2010

With the right technology tools, the sponsor organization and the contract manufacturer can have self-service, on-demand, and scheduled access to all manufacturing, quality, and process-development data.

Process Intelligence Is Critical to the Pharmaceutical Enterprise

Dec 16, 2009

Process intelligence helps users gain a specific understanding of their manufacturing processes and how to control their sources of variability.

Bridging the Development–Manufacturing Gap to Achieve QbD and PAT

Feb 18, 2009

To implement QbD and reduce business risks, teams should begin QbD collaboration early during process development.

Better Process Understanding Improves Quality, Lowers Risk

Jun 2, 2006

Predictable outcomes lead to greater manufacturing efficiency and speed time to value.

Filling the Void: PAT in a Connected Manufacturing Environment

Oct 2, 2003

The author brings attention to the connectivity problems among various data-gathering systems and discusses the drivers and benefits of change, including PAT.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here